APi Group director-linked trust sells 300K shares
APi Group Corp director Ian G.H.
Rhea-AI Filing Summary
APi Group Corp director Ian G.H. Ashken reported that the Nancy and Ian Ashken Investment Trust LLLP sold 300,000 shares of Common Stock on August 3–4, 2026, at weighted average prices of $39.91, $40.33 and $40.76 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 18, 2026. Reported positions include indirect interests in Common Stock through multiple trusts, 1,152,000 underlying shares from Series A Preferred Stock that is convertible into Common Stock, and 4,047 Restricted Stock Units that vest on May 15, 2027; Mr. Ashken disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 300,000 shares
Net Sell
8 txns
Insider
ASHKEN IAN G H
Role
Director
Sold
300,000 shs ($12.01M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F4, F3 | 80,071 | $40.33 | $3.23M |
| Sale | Common Stock F1, F5, F3 | 5,001 | $40.76 | $204K |
| Sale | Common Stock F1, F2, F3 | 214,928 | $39.91 | $8.58M |
| holding | Series A Preferred Stock F9, F8 | -- | -- | -- |
| holding | Restricted Stock Units F10, F11 | -- | -- | -- |
| holding | Common Stock F6 | -- | -- | -- |
| holding | Common Stock F7 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 9,177,284 shares (Indirect, by Nancy and Ian Ashken Investment Trust LLLP);
Series A Preferred Stock — 1,152,000 contracts (Indirect, By Mariposa Acquisition IV, LLC);
Restricted Stock Units — 4,047 contracts (Direct);
Common Stock — 300,000 shares (Indirect, See footnote);
Common Stock — 58,470 shares (Indirect, By Ian G.H. Ashken Living Trust);
Common Stock — 15,552 shares (Indirect, By Mariposa Acquisition IV, LLC)
Footnotes (11)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Nancy and Ian Ashken Investment Trust LLLP (the "Ashken Investment Trust") on March 18, 2026.
- F2. Represents the weighted average price of the shares sold on August 3, 2026. The prices of the shares sold pursuant to the transactions ranged from $39.75 to $40.13 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- F3. The shares of Common Stock reported herein are held directly by the Ashken Investment Trust, the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- F4. Represents the weighted average price of the shares sold on August 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $39.75 to $40.745 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- F5. Represents the weighted average price of the shares sold on August 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $40.75 to $40.765 per share. The Ashken Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- F6. Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust.
- F7. The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- F8. The shares of Common Stock and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Ashken Investment Trust, the general partner of which is wholly-owned by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 15,552 shares of Common Stock and 1,152,000 shares of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- F9. The Series A Preferred Stock will convert into Common Stock at the option of the holder or automatically as of December 31, 2026.
- F10. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- F11. These restricted stock units vest on May 15, 2027, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.
Key Figures
Shares sold: 300,000 shares
Weighted average price 3 Aug 2026: $39.91 per share
Weighted average prices 4 Aug 2026: $40.33 and $40.76 per share
+5 more
8 metrics
Shares sold
300,000 shares
Aggregate Common Stock sales by Ashken-related trust on August 3–4, 2026
Weighted average price 3 Aug 2026
$39.91 per share
Common Stock sales on August 3, 2026
Weighted average prices 4 Aug 2026
$40.33 and $40.76 per share
Two reported Common Stock sale tranches on August 4, 2026
Series A Preferred underlying shares
1,152,000 shares
Underlying Common Stock from Series A Preferred Stock held indirectly
Restricted Stock Units
4,047 units
RSUs each representing one share of Common Stock
Indirect joint account holding
300,000 shares
Common Stock held jointly by Ashken and Nancy K. Ashken Living Trusts
Indirect trust holding
58,470 shares
Common Stock held by the Ian G.H. Ashken Living Trust
Mariposa Common holding
15,552 shares
Common Stock held by Mariposa Acquisition IV, LLC
Key Terms
Rule 10b5-1 trading plan, Restricted Stock Units, Series A Preferred Stock, pecuniary interest, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Series A Preferred Stock financial
"The Series A Preferred Stock will convert into Common Stock at the option of the holder"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
pecuniary interest financial
"may be deemed to have a pecuniary interest in 15,552 shares of Common Stock"
beneficial ownership regulatory
"Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock sales in APi Group Corp (APG) were disclosed?
Entities associated with director Ian G.H. Ashken sold 300,000 shares of APi Group Corp Common Stock on August 3–4, 2026. The Nancy and Ian Ashken Investment Trust LLLP executed these sales in multiple tranches at weighted average prices around $40 per share.
At what prices were the APi Group (APG) insider sales executed?
The reported sales occurred at weighted average prices of $39.91, $40.33 and $40.76 per share. Footnotes state that individual trades on those days ranged between $39.75 and $40.765 per share, with full breakdowns available on request from the selling trust.
Were the APi Group (APG) insider sales under a Rule 10b5-1 plan?
Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted by the Nancy and Ian Ashken Investment Trust LLLP on March 18, 2026. The document-level 10b5-1 checkbox is also marked as affirmed for these transactions.
What APi Group (APG) equity holdings remain after these reported transactions?
Reported positions include indirect holdings of 300,000, 58,470 and 15,552 Common shares through various Ashken-related trusts and entities. In addition, there are 1,152,000 underlying shares from Series A Preferred Stock and 4,047 Restricted Stock Units linked to Common Stock.
When will APi Group (APG) preferred and RSU positions potentially convert or vest?
The filing notes that Series A Preferred Stock held through Mariposa Acquisition IV, LLC will convert into Common Stock at the holder’s option or automatically as of December 31, 2026. The 4,047 RSUs vest on May 15, 2027, subject to continuous service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
